LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Clinical trials for LOCALLY ADVANCED OR METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced breast cancer patients after standard treatment fails
Disease control Recruiting nowThis study is testing whether a new drug called SIM0270, when combined with an existing medication (everolimus), works better than standard treatments for people with advanced breast cancer. It's for patients whose cancer has grown despite previous hormone therapy and a specific …
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 02, 2026 02:42 UTC
-
New drug combo tested for Tough-to-Treat breast cancer
Disease control Recruiting nowThis study is testing whether adding an experimental drug called SPH4336 to standard hormone therapy can help control advanced breast cancer that has continued to grow despite prior treatment. It will involve about 254 adults with hormone-sensitive, HER2-negative breast cancer th…
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE2, PHASE3 • Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New breast cancer combo challenges standard treatment in major trial
Disease control Recruiting nowThis study is testing whether a new drug called HRS-8080, when combined with dalpiciclib, works better than the current standard treatment (fulvestrant with dalpiciclib) for advanced breast cancer that has become resistant to previous hormone therapies. It will involve about 912 …
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC